D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 44 Citations 12,980 83 World Ranking 11068 National Ranking 616

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Amino acid

The scientist’s investigation covers issues in Biochemistry, Stereochemistry, Amino acid, Somatostatin and Structure–activity relationship. Much of his study explores Biochemistry relationship to In vivo. He interconnects Protecting group, Methylation and Thiol in the investigation of issues within Stereochemistry.

His Amino acid research integrates issues from Tetrapeptide, Aqueous medium and Metabolism. His Somatostatin research includes themes of Protein structure, Insulin, Glucagon and Cyclic peptide. His research in Structure–activity relationship intersects with topics in Biological activity and Receptor.

His most cited work include:

  • A potent cyclic hexapeptide analogue of somatostatin (345 citations)
  • Compounds and methods (287 citations)
  • Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260 (287 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Stereochemistry, Biochemistry, Cathepsin K, Pharmacology and Amino acid. His Stereochemistry study integrates concerns from other disciplines, such as Somatostatin, Biological activity, Enzyme inhibitor and Peptide, Peptide synthesis. Daniel F. Veber is investigating Somatostatin as part of his Endocrinology and Internal medicine and Somatostatin study.

His work on Protease, Receptor and Structure–activity relationship as part of general Biochemistry study is frequently connected to Composition, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Cathepsin K research is multidisciplinary, relying on both Cathepsin O, Cathepsin, Enzyme and Cysteine protease. His work carried out in the field of Osteoclast brings together such families of science as Bone resorption and Resorption.

He most often published in these fields:

  • Stereochemistry (31.47%)
  • Biochemistry (27.92%)
  • Cathepsin K (17.26%)

What were the highlights of his more recent work (between 1999-2011)?

  • Biochemistry (27.92%)
  • Cathepsin K (17.26%)
  • Protease (8.63%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Biochemistry, Cathepsin K, Protease, Cathepsin and Stereochemistry. In his research on the topic of Biochemistry, Enzyme inhibitor is strongly related with In vivo. His study in Cathepsin K is interdisciplinary in nature, drawing from both Cathepsin O, Bioavailability and Cysteine protease.

As a member of one scientific family, Daniel F. Veber mostly works in the field of Protease, focusing on Combinatorial chemistry and, on occasion, Scientific method. His Stereochemistry research incorporates elements of Biological activity, In vitro, Ring, Somatostatin and Enzyme. His work investigates the relationship between In vitro and topics such as Receptor that intersect with problems in Protein structure, Peptide sequence, Amino acid and Plasma protein binding.

Between 1999 and 2011, his most popular works were:

  • Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. (140 citations)
  • 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo. (135 citations)
  • Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. (66 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Amino acid

Biochemistry, Stereochemistry, Cathepsin K, In vitro and Enzyme inhibitor are his primary areas of study. Daniel F. Veber works mostly in the field of Biochemistry, limiting it down to topics relating to In vivo and, in certain cases, Endothelial stem cell and Angiogenesis. His Stereochemistry study incorporates themes from Somatostatin, Rumen, Alanine, Sarcosine and Biological activity.

His Cathepsin K research is multidisciplinary, incorporating perspectives in Bone resorption, Cathepsin and Resorption. His In vitro study combines topics from a wide range of disciplines, such as Bioavailability, Pharmacology, Receptor, Combinatorial chemistry and Conformational isomerism. The concepts of his Enzyme inhibitor study are interwoven with issues in Matrigel and Small molecule.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A potent cyclic hexapeptide analogue of somatostatin

Daniel F. Veber;Roger M. Freidinger;Debra Schwenk Perlow;William J. Paleveda.
Nature (1981)

532 Citations

Fibrinogen receptor antagonists

Ruth F. Nutt;Stephen F. Brady;Daniel F. Veber.
Transfusion Science (1993)

490 Citations

Compounds and methods

Joseph P. Marino;Scott K. Thompson;Daniel Frank Veber.
(1998)

442 Citations

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Mark G. Bock;Robert M. DiPardo;Ben E. Evans;Kenneth E. Rittle.
Journal of Medicinal Chemistry (1989)

438 Citations

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

Ben E. Evans;Mark G. Bock;Kenneth E. Rittle;Robert M. Dipardo.
Proceedings of the National Academy of Sciences of the United States of America (1986)

433 Citations

Acetamidomethyl. A Novel Thiol Protecting Group for Cysteine

Daniel Veber;John Milkowski;Sandor Varga;Robert Denkewalter.
Journal of the American Chemical Society (1972)

374 Citations

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

Paul L. Darke;Ruth F. Nutt;Stephen F. Brady;Victor M. Garsky.
Biochemical and Biophysical Research Communications (1988)

361 Citations

Protected lactam-bridged dipeptides for use as conformational constraints in peptides

Roger M. Freidinger;Debra Schwenk Perlow;Daniel F. Veber.
Journal of Organic Chemistry (1982)

258 Citations

Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo

Bartholomew J. Votta;Mark A. Levy;Alison Badger;Jeremy Bradbeer.
Journal of Bone and Mineral Research (1997)

256 Citations

Novel renin inhibitors containing the amino acid statine

Joshua Boger;Nancy S. Lohr;Edgar H. Ulm;Martin Poe.
Nature (1983)

237 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Daniel F. Veber

Horst Kessler

Horst Kessler

Technical University of Munich

Publications: 35

Fernando Albericio

Fernando Albericio

University of KwaZulu-Natal

Publications: 30

Victor J. Hruby

Victor J. Hruby

University of Arizona

Publications: 27

Murray Goodman

Murray Goodman

University of California, San Diego

Publications: 23

Amos B. Smith

Amos B. Smith

University of Pennsylvania

Publications: 21

Ralph Hirschmann

Ralph Hirschmann

University of Pennsylvania

Publications: 21

Andrew V. Schally

Andrew V. Schally

Veterans Health Administration

Publications: 19

Dieter Brömme

Dieter Brömme

University of British Columbia

Publications: 18

Yoshiaki Kiso

Yoshiaki Kiso

Nagahama Institute of Bio-Science and Technology

Publications: 18

Jean Rivier

Jean Rivier

Salk Institute for Biological Studies

Publications: 17

David H. Coy

David H. Coy

Tulane University

Publications: 17

William D. Lubell

William D. Lubell

University of Montreal

Publications: 16

Garland R. Marshall

Garland R. Marshall

Washington University in St. Louis

Publications: 15

Chaim Gilon

Chaim Gilon

Hebrew University of Jerusalem

Publications: 15

Daniel H. Rich

Daniel H. Rich

University of Wisconsin–Madison

Publications: 14

Luis Moroder

Luis Moroder

Max Planck Society

Publications: 14

Trending Scientists

Ton Weijters

Ton Weijters

Eindhoven University of Technology

Ali Reza Saidi

Ali Reza Saidi

Shahid Bahonar University of Kerman

Mahir Alkan

Mahir Alkan

Balıkesir University

Samuel Graham

Samuel Graham

Georgia Institute of Technology

José Bento Sterman Ferraz

José Bento Sterman Ferraz

Universidade de São Paulo

Arnoldus Schytte Blix

Arnoldus Schytte Blix

University of Tromsø - The Arctic University of Norway

Qinghua Cui

Qinghua Cui

Peking University

Tetsuro Okuno

Tetsuro Okuno

Ryukoku University

Juan J. Jiménez

Juan J. Jiménez

Spanish National Research Council

Scott D. Young

Scott D. Young

University of Nottingham

Roger Walz

Roger Walz

Universidade Federal de Santa Catarina

Margaret L. Kern

Margaret L. Kern

University of Melbourne

Rainer Riemann

Rainer Riemann

Bielefeld University

Eric Rice

Eric Rice

University of Southern California

Alvaro Avezum

Alvaro Avezum

University of South Africa

Joseph H. Eberly

Joseph H. Eberly

University of Rochester

Something went wrong. Please try again later.